<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Multiple Active Compounds from Viscum album L. Synergistically Converge to Promote Apoptosis in Ewing Sarcoma</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2016-09-02">September 2, 2016</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Monika</forename><surname>Twardziok</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Pediatric Oncology/Hematology</orgName>
								<orgName type="institution">Otto Heubner Centre for Pediatric and Adolescent Medicine (OHC)</orgName>
								<address>
									<settlement>Charité</settlement>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="institution">Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Germany</settlement>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department" key="dep1">Institute of Pharmacy</orgName>
								<orgName type="department" key="dep2">Department of Biology</orgName>
								<orgName type="institution">Freie Universität</orgName>
								<address>
									<settlement>Chemistry, Pharmacy, Berlin, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Susann</forename><surname>Kleinsimon</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Pediatric Oncology/Hematology</orgName>
								<orgName type="institution">Otto Heubner Centre for Pediatric and Adolescent Medicine (OHC)</orgName>
								<address>
									<settlement>Charité</settlement>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="institution">Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jana</forename><surname>Rolff</surname></persName>
							<affiliation key="aff3">
								<orgName type="department" key="dep1">EPO GmbH</orgName>
								<orgName type="department" key="dep2">Experimental Pharmacology &amp; Oncology</orgName>
								<address>
									<settlement>Berlin, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Sebastian</forename><surname>Jäger</surname></persName>
							<affiliation key="aff4">
								<orgName type="institution">Birken AG</orgName>
								<address>
									<settlement>Niefern-Öschelbronn</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Angelika</forename><surname>Eggert</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Pediatric Oncology/Hematology</orgName>
								<orgName type="institution">Otto Heubner Centre for Pediatric and Adolescent Medicine (OHC)</orgName>
								<address>
									<settlement>Charité</settlement>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="institution">Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName><forename type="first">Georg</forename><surname>Seifert</surname></persName>
							<email>georg.seifert@charite.de</email>
							<affiliation key="aff0">
								<orgName type="department">Department of Pediatric Oncology/Hematology</orgName>
								<orgName type="institution">Otto Heubner Centre for Pediatric and Adolescent Medicine (OHC)</orgName>
								<address>
									<settlement>Charité</settlement>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="institution">Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Catharina</forename><forename type="middle">I</forename><surname>Delebinski</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Pediatric Oncology/Hematology</orgName>
								<orgName type="institution">Otto Heubner Centre for Pediatric and Adolescent Medicine (OHC)</orgName>
								<address>
									<settlement>Charité</settlement>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="institution">Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff5">
								<orgName type="institution">Johns Hopkins University</orgName>
								<address>
									<country key="US">UNITED STATES</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Multiple Active Compounds from Viscum album L. Synergistically Converge to Promote Apoptosis in Ewing Sarcoma</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2016-09-02">September 2, 2016</date>
						</imprint>
					</monogr>
					<idno type="MD5">8BE46B28E1F16ED23927AEDD4D27715B</idno>
					<idno type="DOI">10.1371/journal.pone.0159749</idno>
					<note type="submission">Received: November 24, 2015 Accepted: July 7, 2016</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:45+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>IAP, inhibitor of apoptosis protein</term>
					<term>ML, mistletoe lectin</term>
					<term>TT, triterpene acid-containing extract</term>
					<term>LDH, lactate dehydrogenase</term>
					<term>TBST, Trisbuffered saline with Tween-20</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Ewing sarcoma is the second most common bone cancer in children and adolescents, with poor prognosis and outcome in ~70% of initial diagnoses and 10-15% of relapses.</s><s>Hydrophobic triterpene acids and hydrophilic lectins and viscotoxins from European mistletoe (Viscum album L.) demonstrate anticancer properties, but have not yet been investigated for Ewing sarcoma.</s><s>Commercial Viscum album L. extracts are aqueous, excluding the insoluble triterpenes.</s><s>We recreated a total mistletoe effect by combining an aqueous extract (viscum) and a triterpene extract (TT) solubilized with cyclodextrins.</s><s>Ewing sarcoma cells were treated with viscum, TT and viscumTT in vitro, ex vivo and in vivo.</s><s>In vitro and ex vivo treatment of Ewing sarcoma cells with viscum inhibited proliferation and induced apoptosis in a dose-dependent fashion, while viscumTT combination treatment generated a synergistic effect.</s><s>Apoptosis occurred via intrinsic and extrinsic apoptotic pathways, evidenced by activation of both CASP8 and CASP9.</s><s>We show that viscumTT treatment shifts the balance of apoptotic regulatory proteins towards apoptosis, mainly via CLSPN, MCL1, BIRC5 and XIAP downregulation.</s><s>ViscumTT also demonstrated strong antitumor activity in a cell lineand patient-derived mouse model, and may be considered an adjuvant therapy option for pediatric patients with Ewing sarcoma.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p><s>Ewing sarcoma, while the second most common bone sarcoma in children and adolescents (peaking in the second decade), is rare and occurs in ~2.6 and ~2.8 per million children in the United States and Germany, respectively <ref type="bibr" target="#b0">[1,</ref><ref type="bibr" target="#b1">2]</ref>.</s><s>It originates from either mesenchymal stem or neuronal crest cells <ref type="bibr" target="#b2">[3,</ref><ref type="bibr" target="#b3">4]</ref>.</s><s>Pathogenesis results from a balanced translocation of the EWS gene producing fusion proteins coding for chimeric transcription factors promoting cell growth.</s><s>EWS-FLI1 is the most frequent fusion protein <ref type="bibr" target="#b4">[5,</ref><ref type="bibr" target="#b5">6]</ref>.</s><s>Therapeutic advances in the last few years support five-year survival in 70% of Ewing sarcoma patients.</s><s>Standard therapy currently combines surgery, chemotherapy and radiotherapy, but relapse tumors are often drug resistant <ref type="bibr" target="#b6">[7]</ref>.</s><s>Patient outcome for relapsed Ewing sarcoma is poor, with cure in only 10-15% of patients <ref type="bibr" target="#b7">[8]</ref>.</s><s>Stage, anatomical localization, and tumor size influence prognosis <ref type="bibr" target="#b6">[7]</ref>.</s><s>Expression of the inhibitor of apoptosis protein (IAP) family member, BIRC5 (formerly survivin), is also a poor prognostic factor for Ewing sarcoma <ref type="bibr" target="#b8">[9,</ref><ref type="bibr" target="#b9">10]</ref>.</s><s>BIRC5 has been suggested as an attractive target for new anticancer agents, since it is expressed in many cancers but not in differentiated normal tissues <ref type="bibr" target="#b10">[11]</ref>.</s><s>XIAP, another IAP family member, is also overexpressed in multiple cancers and is associated with drug resistance, making it another promising therapeutic target <ref type="bibr" target="#b11">[12,</ref><ref type="bibr" target="#b12">13]</ref>.</s><s>Combining targeted agents in current protocols might improve survival by reducing resistance development.</s></p><p><s>European mistletoe, Viscum album L., has been popular in anthroposophic medicine for decades.</s><s>A broad range of biologically active substances have been identified in Viscum album L., and include viscotoxins, flavonoids, triterpene acids and mistletoe lectins <ref type="bibr" target="#b13">[14]</ref><ref type="bibr" target="#b14">[15]</ref><ref type="bibr" target="#b15">[16]</ref><ref type="bibr" target="#b16">[17]</ref><ref type="bibr" target="#b17">[18]</ref>. Commercial aqueous Viscum album L. extracts contain the hydrophilic mistletoe lectins (ML) I-III, which are the best studied compounds from mistletoe <ref type="bibr" target="#b18">[19,</ref><ref type="bibr" target="#b19">20]</ref>.</s><s>MLI-III have been demonstrated to stimulate the immune system and induce apoptotic cell death in cell lines derived from head and neck squamous cell carcinomas <ref type="bibr" target="#b20">[21]</ref> and rat glioma <ref type="bibr" target="#b21">[22]</ref> as well as in a single alternatively treated patient with a stage IIIC colon carcinoma <ref type="bibr" target="#b22">[23]</ref>.</s></p><p><s>The hydrophobic triterpene acids, oleanolic, betulinic and ursolic acid, represent another potent group of mistletoe-derived substances, although their low solubilities exclude them from commercially available aqueous extracts <ref type="bibr" target="#b23">[24]</ref>.</s><s>Solubilizing mistletoe triterpene acids (mainly oleanolic and betulinic acids) with cyclodextrins in a buffered aqueous solution produces the triterpene extract, TT.</s><s>Triterpene acids, including oleanolic acid, its derivatives and betulinic acid, inhibit cell growth and induce apoptosis in cell lines derived from breast <ref type="bibr" target="#b24">[25]</ref>, ovarian <ref type="bibr" target="#b25">[26]</ref> and nonsmall cell lung cancers <ref type="bibr" target="#b26">[27]</ref> as well as neuroectodermal tumors in vitro and ex vivo <ref type="bibr" target="#b27">[28]</ref>.</s><s>Combination of oleanolic and ursolic acid has been reported to act synergistically against melanoma cells in vitro and in vivo <ref type="bibr" target="#b28">[29]</ref>.</s></p><p><s>We and others have already demonstrated the therapeutic effect of recombining hydrophilic and hydrophobic mistletoe constituents in the viscumTT extract for acute lymphoblastic and myeloid leukemia in vitro and in vivo <ref type="bibr" target="#b29">[30,</ref><ref type="bibr" target="#b30">31]</ref> and murine melanoma in vivo <ref type="bibr" target="#b31">[32]</ref>.</s><s>Here, we analyzed for the first time the cytotoxic effect of viscumTT and its single extracts in Ewing sarcoma in vitro, ex vivo and in vivo.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Materials and Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Viscum album L. extracts</head><p><s>Viscum and TT extracts were prepared from Viscum album L. harvested from apple trees (malus) as previously described <ref type="bibr" target="#b29">[30,</ref><ref type="bibr" target="#b30">31,</ref><ref type="bibr" target="#b32">33]</ref> by the Birken AG (Niefern-Oeschelbronn, Germany), who kindly provided lyophilized viscum and TT extracts.</s><s>Intact ML-I (with A+B chain) was quantified by ELISA in viscum extract <ref type="bibr" target="#b33">[34]</ref>.</s><s>Oleanolic acid and betulinic acid quantification was performed by GC-FID <ref type="bibr" target="#b32">[33]</ref>.</s><s>Lyophilized viscum extract was reconstituted in phosphate-buffered saline (Gibco 1 Life Technologies, Darmstadt, Germany) to a final concentration of 2μg/mL intact ML-I and &lt;1μg/mL viscotoxins.</s><s>Lyophilized TT extract (containing cyclodextrins) was reconstituted in phosphate-buffered saline to a final concentration of 4000μg/mL oleanolic and 350μg/mL betulinic acid.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Cell culture</head><p><s>Human Ewing sarcoma cell lines were obtained from the German Collection of Microorganisms and Cell Cultures (DSMZ, Braunschweig, Germany).</s><s>TC-71 was maintained in Iscove's Modified Dulbecco's Medium with L-glutamine (Gibco 1 Life Technologies, Darmstadt, Germany).</s><s>MHH-ES-1 was maintained RPMI 1640 base medium with L-glutamine (Gibco Lifetechnologies).</s><s>Base media were supplemented with 10% heat-inactivated fetal calf serum (Biochrom, Berlin, Germany), 100U/mL penicillin and 100μg/mL streptomycin (Biochrom).</s><s>For assays, 2x10 5 TC-71 cells and 4x10 5 MHH-ES-1 cells were seeded onto 6-well plates (half the cell number onto 12-well microtiter plates), cultured 24h to allow cell attachment and treated 24h with Viscum album L. extracts added to culture media.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Ex vivo cultured Ewing sarcoma primary cells</head><p><s>A tumor sample was obtained as treatment 'residue' from a 15-year-old girl with Ewing sarcoma during routine surgical resection, and was not explicitly collected for this research.</s><s>Diagnosis was confirmed by histopathology.</s><s>The sample was dissected into smaller pieces immediately after surgical excision, then cultured as a primary explant in RPMI 1640 base medium with L-glutamine supplemented with 20% heat-inactivated fetal calf serum and 1% penicillin/streptomycin solution (Biochrom) to obtain dissociated monolayer culture outgrowth from the explant.</s><s>Confluent ex vivo cell cultures were treated within 4 trypsinized passages.</s><s>CD99 expression confirmed ex vivo cultures to be Ewing sarcoma using immunocytochemistry and flow cytometry with FITC-labeled anti-CD99 antibody (#561986, BD Biosciences, Franklin Lakes, NJ, USA) versus the isotype control antibody (#555573).</s><s>FISH confirmed the EWS-ETS translocation in the ex vivo culture.</s><s>Cells were seeded into 12-well microtiter plates at 1.3x10 5 /well, cultured 24h to allow cell attachment and treated 24h with Viscum album L. extracts added to culture media.</s><s>Written informed consent was obtained from the patient's parents and/or legal guardians in accordance with the Declaration of Helsinki, approved by the local ethics committee of Charité-Universitätsmedizin Berlin.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Ewing sarcoma xenografts and experimental procedures</head><p><s>Eight-week-old female NOD/SCID IL2rγ null mice and 6-8-weeks-old female NMRI-nu/nu mice were obtained from Taconic or in-house breeding, housed in a pathogen-free facility under pathogen-free conditions and fed autoclaved standard diet (Sniff, Soest, Germany) with acidified drinking water ad libitum.</s></p><p><s>A) TC-71 cells (1x10 6 ) were subcutaneously injected in saline into the left flank of 8 NOD/ SCID IL2rγ null mice per treatment or control group.</s><s>Intratumoral treatment with viscum, TT, viscumTT or cyclodextrins alone (control group) began on day 12 when tumors were palpable.</s><s>Intravenous treatment with viscumTT or cyclodextrins began on day 3 after tumor cell injection.</s><s>Mice were treated with increasing extract concentrations due to better tolerability: 40/50/ 60mg/kg oleanolic acid (TT), 0.75/1.25/1.75μg/kg</s><s>mistletoe lectin (viscum) or a combination thereof (viscumTT).</s><s>Doses were administered every 2-3 days (Mon/Wed/Fri/Mon/Fri) in increasing concentrations and each concentration was given twice within 2-3 days due to better tolerability of the mistletoe extracts.</s><s>The standard-of-care group received doxorubicin with 4 mg/kg once, intravenously on day 12.</s></p><p><s>B) Patient-derived Ewing sarcoma fragments were subcutaneously transplanted into the left flank of 5 mice per treatment or control group.</s><s>Intratumoral and intravenous treatment with viscumTT, cyclodextrins alone or doxorubicin (positive control group) began on day 48 when tumors were palpable.</s><s>Mice were treated with increasing extract concentrations of 40/60/ 80mg/kg oleanolic acid and 0.75/1.25/1.75μg/kg</s><s>mistletoe lectin in combination (viscumTT, low dose) or 50/70/90mg/kg oleanolic acid and 1.25/1.75/2.25μg/kg</s><s>mistletoe lectin in combination (viscumTT, high dose).</s><s>Doses were administered every 2-3 days (Wed/Fri/Mon/Wed/ Fri/Mon) in increasing concentrations and each concentration was given twice within 2-3 days.</s><s>One positive control group received doxorubicin, 4 mg/kg, intravenously on day 48 and day 55.</s></p><p><s>Body weight and tumor volume was measured twice weekly, and mice were daily monitored for health and symptoms of toxicity.</s><s>Animals were sacrificed by cervical dislocation at the end of the experiment or if mice were moribund (tumor volume &gt;1.2cm 3 or &gt;10% body weight lost).</s><s>Animal experiments were performed in accordance with German legislation on the care and use of laboratory animals and in accordance with the United Kingdom Coordinating Committee on Cancer Research Guidelines for the Welfare of animals in Experimental Neoplasia to minimize suffering.</s><s>Approval for the study was obtained from the Regional Office for Health and Social Affairs (LaGeSo, approval G-0030/15).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Determining cell proliferation and early cytotoxicity</head><p><s>Cells were counted using a CASY 1 Cell Counter (Schaerfe System GmbH, Reutlingen, Germany).</s><s>Cell proliferation was estimated from total numbers of cells in cultures started from defined cell numbers compared to control cultures.</s><s>Early cytotoxicity was assessed after 2h of incubation with extracts by photometrically (490nm) monitoring lactate dehydrogenase (LDH) release into culture medium using the Cytotoxicity Detection Kit (Roche Diagnostics GmbH, Mannheim, Germany) according to manufacturer´s instructions.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Assessing apoptotic cell death</head><p><s>Cells were stained with APC-conjugated annexin V (BD Biosciences) and 1 mg/mL propidium iodide (Sigma-Aldrich, München, Germany) according to manufacturer's instructions to assess apoptosis.</s><s>The mitochondrial membrane potential (ΔC m ) was measured by JC-1 staining (AAT Bioquest, Sunnyvale, CA, USA) according to manufacturer's instructions.</s><s>CASP3, CASP8 and CASP9 activity were measured using the Green Caspase Staining Kit (Promokine, Heidelberg, Germany) with the nontoxic, irreversibly caspase-binding cell-permeable FIT-C-LEHD-FMK, FITC-IETD-FMK or FITC-DEVD-FMK, according to manufacturer's directions.</s><s>Cells stained using any of these protocols were analyzed by flow cytometry (FACS Calibur, BD Biosciences), and results were evaluated with FlowJo Software (TreeStar, Ashland, OR, USA).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Caspase inhibitor assay</head><p><s>TC-71 cells were incubated with 40μM Z-VAD-FMK (R&amp;D systems, Minneapolis, MN, USA), a pan-caspase inhibitor before treatment with viscum, TT or viscumTT extracts at ~IC50 concentrations.</s><s>DMSO was added to extracts as solvent control.</s><s>Apoptotic induction was determined by flow cytometry after annexin V/propidium iodide staining.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Proteome profiler human apoptosis array and western blotting</head><p><s>TC-71 cells were washed twice with phosphate-buffered saline, lysed in Lysis Buffer 17 (R&amp;D systems) containing complete Protease Inhibitor Cocktail (Roche Diagnostics GmbH) and protein concentration determined by Bradford assay (Bio-Rad, München, Germany).</s><s>Lysate (300μg protein) was incubated with the Proteome Profiler Human Apoptosis Array (R&amp;D systems) according to manufacturer´s instructions.</s><s>Chemoluminescence was visualized by densitometry on a Molecular Imager ChemiDoc (Bio-Rad) to detect relative expression of apoptosis-related proteins.</s><s>Expression was validated using western blotting.</s><s>TC-71 and MHH-ES-1 cell lysates (30μg protein/lane) were separated on SDS-PAGE, transferred to nitrocellulose membranes (Bio-Rad system) and blocked with 5% nonfat milk in 50mM TBS with 0.05% Tween-20 (TBST) for 1h at room temperature.</s><s>Blots were incubated overnight at 4°C in TBST containing 5% bovine serum albumin and primary antibody, washed 3X in TBST and incubated 1h with HRP-conjugated secondary antibodies (ant-rabbit or anti-mouse, Bio-Rad), then visualized by ECL (Thermo Fisher Scientific, Bonn, Germany) on a Molecular Imager ChemiDoc (Bio-Rad).</s><s>Primary antibodies used were directed against CASP3 (#9662, Cell Signaling Technology, Danvers, MN, USA), PARP1 (#9542, Cell Signaling Technology), CLSPN (#2800, Cell Signaling Technology), BIRC5 (#2803, Cell Signaling Technology), TP53 (sc-73566, Santa Cruz Biotechnology, Santa Cruz, CA, USA), PMAIP1 (sc-56169, Santa Cruz Biotechnology) and MCL1 (sc-819, Santa Cruz Biotechnology), XIAP (#610716, BD Biosciences) and ß-actin (#A3854, Sigma-Aldrich).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistics</head><p><s>In vitro experiments (except the Proteome Profiler Human Apoptosis Array) were performed in three independent experiments, for which means ±standard error are plotted in bar graphs.</s><s>A Webb´s fractional product (Fp) &gt;1 determined that the effect of viscumTT on apoptotic induction in vitro and ex vivo was synergistic, as described <ref type="bibr" target="#b29">[30]</ref>.</s><s>One-way ANOVA and Fisher ´s LSD post-hoc tests were applied to determine differences between mouse xenograft treatment groups.</s><s>All results with p 0.05 were considered significant.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>ViscumTT inhibits proliferation and induces apoptosis in vitro</head><p><s>We first assessed the cytotoxic potential of aqueous and triterpene components separately or in combination on Ewing cell lines in vitro to examine which extracts contained effectors from Viscum album L. and detect potential synergies.</s><s>TC-71 and MHH-ES-1 cell proliferation was measured after incubation with increasing concentrations of viscum, TT or viscumTT.</s><s>Vis-cumTT and viscum inhibited proliferation in a concentration-dependent manner in both cell lines (Fig <ref type="figure" target="#fig_2">1</ref>  <ref type="table">)</ref>.</s><s>To exclude the possibility that extracts caused early cytotoxicity via necrotic cell death, LDH release from cells into culture medium was measured after a 2h treatment pulse.</s><s>Neither cell line released significant amounts of LDH in response to treatment with any extract (Fig <ref type="figure" target="#fig_2">1</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>and S1 Table). TT had no effect on MHH-ES-1 cells, but displayed a low inhibitory effect in TC-71 cells (Fig 1 and S1 Table</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>ViscumTT induces apoptosis via mitochondrial depolarization and activates caspases in vitro</head><p><s>To more closely assess the mechanism behind viscumTT cytotoxicity, we analyzed mitochondrial involvement and caspase activation during apoptotic induction in TC-71 and MHH-ES-1 cells, since most chemotherapeutic drugs induce mitochondrial membrane permeabilization as they induce apoptosis <ref type="bibr" target="#b34">[35,</ref><ref type="bibr" target="#b35">36]</ref>  <ref type="table">)</ref>.</s><s>Similar to its effect on apoptosis, viscumTT synergistically affected mitochondrial membrane depolarization, peaking at an 80% suppression of membrane potential in both Ewing sarcoma cell lines <ref type="bibr">(Fig 2C and S1 Table)</ref>.</s><s>TT treatment alone did not significantly affect mitochondrial membrane potential in either cell line <ref type="bibr">(Fig 2C and S1 Table)</ref>.</s><s>We also measured the activation of CASP8, CASP9 and CASP3 in TC-71 and</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Viscum, TT and viscumTT alter apoptosis-related protein expression</head><p><s>To more closely examine how mistletoe-derived cytotoxic agents induce apoptosis in Ewing sarcoma cells, we analyzed the expression of 35 proteins related to apoptosis using the R&amp;D Systems human proteome profiler apoptosis array.</s><s>TC-71 cells were treated with ~IC50 concentrations of viscum, TT or viscumTT.</s><s>The array detected a shift of many proteins associated with apoptosis in protein extracts from the treatment groups.</s><s>Viscum, TT and viscumTT reduced expression of the IAP family members, BIRC2 (cIAP1), BIRC3 (cIAP2), XIAP and BIRC5, and to a lesser extent, BCL2 protein and TP53, compared to untreated control cells (Fig <ref type="figure" target="#fig_7">4A</ref>).</s><s>BIRC5 downregulation was particularly prominent.</s><s>Altogether, expression shifted the balance towards less anti-apoptotic protein expression.</s><s>Interestingly, the expression of claspin (CLSPN), a protein needed for efficient DNA replication, was strongly suppressed by viscum, TT and viscumTT.</s><s>TT also strongly upregulated expression of the heat shock 60kDa protein 1 (HSPD1).</s><s>Since the array could only be performed on a single treatment experiment, we validated results in TC71 and MHH-ES-1 lysates from three independent experiments using western blotting.</s><s>Western blots confirmed that viscum, TT and viscumTT downregulated BIRC5, XIAP, TP53 and CLSPN in Ewing sarcoma cells in vitro (Fig <ref type="figure" target="#fig_7">4B</ref>).</s><s>Since the pro-apoptotic BCL2 family member, PMAIP1 (NOXA), was shown to play a role in apoptosis induced by betulinic acid and doxorubicin polychemotherapy <ref type="bibr" target="#b36">[37]</ref>, we also analyzed PMAIP1 expression in extracts from cells treated with viscum, TT or viscumTT.</s><s>TT treatment upregulated PMAIP1 expression in both cell lines, whereas viscum or viscumTT did not affect expression compared to the control (Fig <ref type="figure" target="#fig_7">4B</ref>).</s><s>ViscumTT and viscum, but not TT, effectively downregulated the anti-apoptotic protein, MCL1, in both cell lines compared to untreated control cells (Fig <ref type="figure" target="#fig_7">4B</ref>).</s><s>These data suggest that TT upregulates pro-apoptotic PMAIP1 but is incapable of downregulating MCL1, possibly explaining the less effective apoptotic induction of TT extract alone.</s><s>Taken together, our results indicate that cytotoxic agents derived from mistletoe invoke several signaling pathways to induce apoptosis, which explains the synergistic effect of reconstituting a complete mistletoe extract in viscumTT.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>ViscumTT and viscum induce apoptosis and inhibit proliferation ex vivo and reduce xenograft tumor growth</head><p><s>We proceeded to verify our in vitro results in primary Ewing sarcoma cells grown ex vivo and in human Ewing sarcoma xenograft tumors grown in nude mice.</s><s>Ex vivo cultures of primary Ewing sarcoma cells were treated with increasing concentrations of viscum, TT and viscumTT for 24h.</s><s>TT alone had no effect on primary Ewing sarcoma cells ex vivo (  <ref type="table">)</ref>.</s><s>Importantly, we also validated the synergistic effect of viscumTT in primary Ewing sarcoma cells ex vivo (Fig 5 and S1 Table <ref type="table">)</ref>.</s><s>We next tested the effect of viscum, TT and viscumTT on the established human Ewing sarcoma cell line TC-71 grown subcutaneously in female NOD/ SCID IL2rγ null mice.</s><s>Extracts were injected intratumorally every 2-3 days in increasing  derived xenograft was treated with viscumTT that was injected intratumorally (low and high dose) or intravenously (low dose) every 2-3 days in increasing concentrations and a total of nine treatments.</s><s>We included a positive control group that received twice an intravenous dose of doxorubicin (Fig <ref type="figure" target="#fig_11">7</ref>).</s><s>The negative control group received cyclodextrins intratumorally (Fig <ref type="figure" target="#fig_11">7</ref>).</s><s>Again, the administered extract concentrations were well-tolerated by mice, which displayed no significant weight loss or toxicity symptoms.</s><s>The intratumorally injected low and high dose of viscumTT significantly inhibited tumor growth by 66-71% (as assessed from final measurement of mean tumor volumes compared to controls intratumorally injected with cyclodextrins alone).</s><s>By contrast, intravenously administered viscumTT and doxorubicin did not inhibit tumor growth significantly.</s><s>Taken together, reconstituting whole mistletoe extract in viscumTT synergistically induced apoptosis in primary Ewing sarcoma cells ex vivo and effectively suppressed Ewing sarcoma growth in xenograft mouse models.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p><s>The combined mistletoe extract, viscumTT, inhibits proliferation and induces apoptosis in Ewing sarcoma cells in vitro and ex vivo, and efficiently reduces xenograft tumor volume in vivo.</s><s>While viscum alone showed similar but less effective anticancer activity in vitro and ex vivo, the triterpene extract, TT, displayed significant activity only against TC-71 cells in vitro and TC-71 xenografts in vivo.</s><s>Although it is ineffective against MHH-ES-1 and primary Ewing sarcoma cells, TT appears to potentiate the effect of viscum, creating the synergistic effect of viscumTT.</s><s>Our data correlates with the well-known phytopharmacological phenomenon that a naturally existing combination is often more effective than the single compounds <ref type="bibr" target="#b37">[38,</ref><ref type="bibr" target="#b38">39]</ref>.</s></p><p><s>Our in vitro and ex vivo experiments showed viscumTT and viscum invoke both intrinsic and extrinsic pathways of apoptosis in Ewing sarcoma cells.</s><s>Treatment of TC-71 cells with a pan-caspase inhibitor verified that apoptosis was caspase-dependent.</s><s>This is in line with previous data from hepatocellular carcinoma and leukemia <ref type="bibr" target="#b29">[30,</ref><ref type="bibr" target="#b39">[40]</ref><ref type="bibr" target="#b40">[41]</ref><ref type="bibr" target="#b41">[42]</ref>.</s><s>Notably, MHH-ES-1 cells and the primary cells were more resistant to mistletoe extracts than TC-71 cells, and required ~15-fold higher viscum concentrations to reach IC50.</s><s>This demonstrates a variable responsiveness of different cell populations to viscum and viscumTT.</s><s>Variable susceptibility could stem from different cell surface characteristics (glycocalyx), since mistletoe lectins specifically bind to D-galactose and/or N-acetyl-D-galactosamine <ref type="bibr" target="#b14">[15]</ref> and therefore response to mistletoe lectins is cell-type-dependent <ref type="bibr" target="#b42">[43]</ref>.</s><s>TT proved less cytotoxic than either viscumTT or viscum against Ewing sarcoma cells.</s><s>TT also did not activate CASP8, CASP9 or CASP3 or cause mitochondrial membrane depolarization, indicating other mechanisms cause the moderate TTmediated apoptosis and proliferative inhibition in TC-71 cells.</s><s>Triterpene acids, such as ursolic acid and oleanolic acid and its derivatives, have previously been shown to induce apoptosis in osteosarcoma, breast and pancreatic cancers via extrinsic or intrinsic pathways requiring caspases <ref type="bibr" target="#b24">[25,</ref><ref type="bibr" target="#b43">[44]</ref><ref type="bibr" target="#b44">[45]</ref><ref type="bibr" target="#b45">[46]</ref><ref type="bibr" target="#b46">[47]</ref><ref type="bibr" target="#b47">[48]</ref>.</s><s>Oleanolic acid and its derivative have also been shown to induce apoptosis without caspase participation in pancreatic cancer cells and acute myelogenous leukemia <ref type="bibr" target="#b48">[49,</ref><ref type="bibr" target="#b49">50]</ref>, suggesting that the triterpene effect is cell type-dependent.</s></p><p><s>Our deeper assessment of the apoptotic mechanism after mistletoe extract treatment in vitro revealed altered expression of diverse apoptosis-related proteins shifting the balance towards apoptosis.</s><s>Treatment with viscumTT and viscum effectively reduced expression of the anti-apoptotic protein, MCL1.</s><s>The MCL1 downregulation in Ewing sarcoma cell lines agrees with previous data demonstrating MCL1 downregulation by mistletoe lectins in leukemia cells <ref type="bibr" target="#b50">[51]</ref> and by an oleanolic acid derivative in osteosarcoma cells <ref type="bibr" target="#b51">[52]</ref>.</s><s>TT strongly upregulated the PMAIP1 pro-apoptotic protein in both Ewing sarcoma cell lines, but didn't affect MCL1 ) or a combination thereof (viscumTT i.t.) every 2 to 3 days in increasing concentrations.</s><s>Each concentration was administered twice within 2-3 days.</s><s>One treatment group received viscumTT intravenously (i.v.), and one positive control group was once intravenously (i.v.) treated with 4 mg/kg doxorubicin.</s><s>The negative control group received the solubilizing agent, cyclodextrins (CD), which was injected either intratumorally (CD i.t.) or intravenously (CD i.v.).</s><s>One-way ANOVA revealed a significant group effect (p = 0.007) and Fisher´s Least Significant Difference test comparing all groups with all groups showed a significant effect between the CD i. expression resulting in less effective apoptosis induction.</s><s>PMAIP1 upregulation together with downregulation of the anti-apoptotic BCL2L1 protein have been correlated with increased apoptosis in pancreatic tumor cells treated with an oleanolic acid derivative <ref type="bibr" target="#b52">[53]</ref>.</s><s>Erhardt et al. reported that PMAIP1 is involved in apoptotic induction by drug combinations, such as doxorubicin and betulinic acid in diverse cancer cell lines, including breast, colon and leukemia <ref type="bibr" target="#b36">[37]</ref>.</s><s>ViscumTT contains oleanolic and betulinic acid, viscotoxins, mistletoe lectins and other undefined components, which together produce a phytopolychemotherapeutic effect.</s><s>But unlike TT, viscumTT did not upregulate PMAIP1 expression in Ewing sarcoma cells, indicating PMAIP1 regulation is not involved in the synergistic effect produced by viscumTT.</s><s>Mistletoe extracts also suppressed TP53 expression in Ewing sarcoma cell lines, but this effect is less ) and intravenously (i.v.) injected with 40/60/80mg/kg oleanolic acid and 1.25/1.75/2.25μg/kg</s><s>mistletoe lectin in combination (viscumTT, low dose).</s><s>Additionally, mice were treated intratumorally (i.t.) with 50/70/90mg/kg oleanolic acid and 1.25/1.75/</s><s>2.25μg/kg mistletoe lectin in combination (viscumTT, high dose).</s><s>Viscum TT was given every 2-3 days in increasing extract concentrations.</s><s>One positive control group was treated twice intravenously (i.v.) with 4 mg/kg doxorubicin.</s><s>The negative control group received cyclodextrins (CD) intratumorally (CD i.t.).</s><s>One-way ANOVA revealed a strongly significant group effect (p &lt; 0.0001) and Fisher´s Least Significant Difference test comparing all groups with all groups showed a significant effect between the CD i.t.</s><s>control group and viscumTT i. meaningful since TC-71 expresses an inactive TP53 mutant protein <ref type="bibr" target="#b53">[54]</ref> and MHH-ES-1 harbors an in-frame deletion of Ser215 in the TP53 transactivation domain.</s><s>The downregulation might indicate signaling is in place that would trigger downregulation of the wild type tumor suppressor.</s><s>However, this must not mean it would have an anti-apoptotic effect, since mistletoe lectins both suppressed wild type TP53 expression and induced apoptosis in human lymphocytes <ref type="bibr" target="#b54">[55]</ref>.</s><s>Other reports did not analyze TP53 expression directly, but also showed that Viscum album L. induced apoptosis in cell lines (SMMC7721 hepatocellular carcinoma and NALM-6 acute lymphoblastic leukemia cells) harboring wild type TP53 <ref type="bibr" target="#b29">[30,</ref><ref type="bibr" target="#b41">42]</ref>.</s><s>CLSPN expression was also decreased in both cell lines after treatment with viscumTT or either single extract.</s><s>It is required for efficient DNA replication during a normal S phase and has been shown to promote cancer cell survival <ref type="bibr" target="#b55">[56]</ref>.</s><s>CLSPN is an essential upstream regulator of checkpoint kinase 1, and triggers cell cycle arrest in response to replicative stress or DNA damage.</s><s>In a previous study, we showed that mistletoe extracts similarly reduced CLSPN expression in acute myeloid leukemia cells, where extracts also induced apoptosis and inhibited proliferation <ref type="bibr" target="#b30">[31]</ref>.</s><s>Mistletoe extracts also reduced XIAP and BIRC5 expression in Ewing sarcoma cells.</s><s>The IAP family regulates cell death by inhibiting caspases or the assembly of pro-apoptotic protein complexes, and mediating the expression of anti-apoptotic proteins <ref type="bibr" target="#b56">[57,</ref><ref type="bibr" target="#b57">58]</ref>.</s><s>Since BIRC5 expression is associated with chemo-and radioresistance in Ewing sarcoma and poor patient prognosis <ref type="bibr" target="#b8">[9,</ref><ref type="bibr" target="#b9">10]</ref>, BIRC5 downregulation by Viscum album L. extracts makes it an interesting candidate for targeting Ewing sarcoma.</s><s>We previously achieved a similar effect with acute myeloid leukemia cells <ref type="bibr" target="#b30">[31]</ref>.</s><s>Oleanolic and ursolic acid have also been shown to induce apoptosis and downregulate XIAP in hepatocellular carcinoma cells <ref type="bibr" target="#b46">[47]</ref>, while oleanolic acid decreased BIRC5 expression in human nonsmall cell lung cancer and ovarian cancer cells <ref type="bibr" target="#b26">[27,</ref><ref type="bibr" target="#b58">59]</ref> and betulinic acid derivatives downregulated BIRC5 in glioblastoma cell lines <ref type="bibr" target="#b59">[60]</ref>.</s><s>Taken together, our in vitro data shows that viscumTT combines the anti-cancer effects derived from triterpene acids and mistletoe lectins, and pro-apoptotically shifts the balance of apoptosis-related proteins, suggesting this effect is not cancer-type dependent.</s></p><p><s>The anticancer effects we observed for mistletoe extract ex vivo and in vitro, were confirmed in vivo in a TC-71 cell line and patient-derived xenograft model for Ewing sarcoma.</s><s>In the TC-71 xenograft, all extracts inhibited the tumor growth significantly when injected intratumorally.</s><s>Intravenous injection of viscumTT had a comparable effect on the tumor growth to doxorubicin treatment.</s><s>However, doxorubicin was applied only once due to bad tolerability in mice.</s><s>Still, this also emphasizes the good tolerability of the used mistletoe extracts.</s><s>Noteworthy, we were not able to observe a synergistic effect of viscumTT in vivo.</s><s>However, identical results in vitro and in vivo are impossible, since a living organism is more than one cell type and the extracts are metabolized in the body.</s><s>Unfortunately, there is literature lacking showing the pharmacokinetics of mistletoe extracts in mice or humans, but Huber et al. showed for subcutaneous injections in humans, that serum mistletoe lectin levels are highly variable after injection <ref type="bibr" target="#b60">[61]</ref>.</s><s>Furthermore, Frantz et al. demonstrated, that mistletoe lectins can also bind Serum glycoproteins as haptoglobin, alpha 1-acid glycoprotein and transferrin inhibiting the cytotoxicity of the lectins <ref type="bibr" target="#b61">[62]</ref> Although viscumTT had no synergistic effect in vivo, it still demonstrated effectiveness intratumorally and intravenously.</s><s>To validate the effect of viscumTT in vivo, we injected viscumTT in a patient-derived xenograft model intratumorally and intravenously.</s><s>The intratumorally injected viscumTT in low and high dose significantly reduced tumor growth, while twice application of doxorubicin showed no significant tumor reduction.</s><s>Notably, viscumTT intratumoral displayed different results depending on the used mouse stem demonstrating the difficulties to evaluate in vitro results in vivo.</s><s>Mistletoe lectins have also been reported to have an anticancer effect in mouse models for melanoma, pre-B ALL and lymphosarcoma <ref type="bibr" target="#b62">[63]</ref><ref type="bibr" target="#b63">[64]</ref><ref type="bibr" target="#b64">[65]</ref>, as were oleanolic acid and its derivatives in mouse models of melanoma, osteosarcoma and lung cancer <ref type="bibr" target="#b26">[27,</ref><ref type="bibr" target="#b65">66,</ref><ref type="bibr" target="#b66">67]</ref>.</s><s>We and others have previously demonstrated the in vivo efficacy of viscumTT against mouse models of acute lymphoblastic leukemia and melanoma <ref type="bibr" target="#b29">[30,</ref><ref type="bibr" target="#b32">33]</ref>.</s></p><p><s>Here we demonstrate that reconstituting the aqueous and triterpene components from mistletoe in the viscumTT extract synergistically induces caspase-dependent apoptosis associated with CLSPN, MCL1, BIRC5 and XIAP downregulation in Ewing sarcoma cell lines in vitro and primary cells ex vivo.</s><s>ViscumTT also reduced tumor growth in TC-71-derived and patientderived Ewing sarcoma xenografts.</s><s>ViscumTT may represent a phytopolychemotherapeutic option as a promising adjuvant therapy for patients with Ewing sarcoma.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Supporting Information</head><p><s>S1 Table <ref type="table">.</ref></s><s>All in vitro and ex vivo measurements.</s><s>TC-71 cells, MHH-ES-1 cells and Ewing sarcoma primary cells were incubated for 24 h with the extracts in depicted concentrations followed by measurements of apoptosis, proliferation, mitochondria membrane potential (JC-1), active caspases, LDH.</s><s>(XLSX)</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head></head><label></label><figDesc><div><p><s>and S1 Table).</s><s>We flow cytometrically assessed the fraction of TC-71 and MHH-ES-1 cells undergoing apoptosis in response to 24h incubation with Viscum album L. extracts after annexin V/propidium iodide staining.</s><s>ViscumTT and viscum induced apoptosis in both cell lines in a dose-dependent manner, whereas TT only induced apoptosis in TC-71 cells(Fig 2A and S1 Table).</s><s>Importantly, the reconstituted viscumTT extract displayed a synergistic effect on apoptosis in both cell lines(Fig 2A and S1 Table).</s><s>Western blot analyses detecting PARP1 and CASP3 cleavage confirmed cells died from apoptotic induction (Fig 2B).</s><s>Taken together, reconstituting Viscum album L. cytotoxic compounds in viscumTT had a synergistic and dose-dependent effect on proliferation and apoptosis in Ewing sarcoma cell lines.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head></head><label></label><figDesc><div><p><s>. Cell cultures treated for 24h with viscum, TT or viscumTT extracts were flow cytometrically assessed after JC-1 staining to detect mitochondrial membrane potentials relative to untreated control cultures.</s><s>Treatment with viscumTT or viscum alone resulted in a dose-dependent loss of mitochondrial membrane potential in TC-71 and MHH-ES-1 cells (Fig 2C and S1 Table</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Fig 1 .</head><label>1</label><figDesc><div><p><s>Fig 1.ViscumTT inhibits proliferation in Ewing sarcoma cell lines without early cytotoxicity.</s><s>TC-71 and MHH-ES-1 cells were treated with increasing concentrations of TT, viscum or viscumTT for 24h and proliferation was estimated from total cell numbers in cultures started from defined cell numbers compared to control cultures (upper graphs).</s><s>Cells were counted using a CASY 1 Cell Counter.</s><s>TC-71 and MHH-ES-1 cells were incubated with increasing concentrations of viscum, TT or viscumTT for 2h, before assessing early cytotoxicity via LDH release into the culture medium (lower graphs).</s><s>All results are presented as the percentage of untreated control (Ctrl) cultures ± SD, and are the mean of 3 independent experiments.</s><s>Mistletoe lectin (ML) and oleanolic acid (OA) concentrations were used as a measure of viscum and TT active agent extract concentration, respectively.</s><s>doi:10.1371/journal.pone.0159749.g001</s></p></div></figDesc><graphic coords="6,48.98,78.01,527.02,408.36" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Fig 2 .</head><label>2</label><figDesc><div><p><s>Fig 2. ViscumTT combined extract synergistically induces apoptosis in Ewing sarcoma cell lines.</s><s>A. TC-71 and MHH-ES-1 cells were incubated for 24h with increasing concentrations of viscum, TT and viscumTT.</s><s>Cultures were then stained with annexin V and propidium iodide and examined by flow cytometry.</s><s>The percentage of dead cells in each treatment group are shown (±SD) from 3 independent experiments.</s><s>A synergistic effect of the combined viscumTT extract above single extracts was calculated by Webb´s fractional product (*Fp &gt; 1).</s><s>B. PARP1 and CASP3 cleavage was assessed in whole-cell extracts from cells treated as described above using western blotting.</s><s>β-actin was used as loading control, and images shown are representative for the results in 3 independent experiments.</s><s>C. TC-71 and MHH-ES-1 cells treated as above for 24h and were assessed for mitochondrial involvement in apoptosis using JC-1 staining and flow cytometry.</s><s>Bars depict the percentage of cells with low mitochondrial membrane potential (ΔΨ m , ± SD, n = 3) in each treatment group averaged from 3 independent experiments (±SD, error bars).</s><s>A synergistic effect of combined viscumTT extracts was</s></p></div></figDesc><graphic coords="7,47.96,78.01,528.23,546.86" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head></head><label></label><figDesc><div><p><s>calculated by Webb´s fractional product (*Fp &gt; 1).</s><s>Carbonyl cyanide m-chlorophenyl hydrazine (CCCP) was used as positive control.</s><s>Mistletoe lectin (ML) and oleanolic acid (OA) concentrations were used as a measure of viscum and TT active agent extract concentration, respectively.</s><s>doi:10.1371/journal.pone.0159749.g002</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_5"><head></head><label></label><figDesc><div><p><s>Fig 5 and S1 Table), similarly to MHH-ES-1 cells.</s><s>Treatment with viscum or viscumTT induced apoptosis in a concentration-dependent manner in primary Ewing sarcoma cells ex vivo, leading to mitochondrial membrane depolarization and CASP8 and CASP9 activation (Fig 5 and S1 Table</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_6"><head>Fig 3 .</head><label>3</label><figDesc><div><p><s>Fig 3. ViscumTT synergistically activates caspases in Ewing sarcoma cells lines above the levels activated by viscum alone.</s><s>A. TC-71 and MHH-ES-1 cells treated 24h with either viscum, TT or viscumTT.</s><s>CASP9, CASP8, CASP3 activation was measured using FITC-LEHD-FMK, FITC-IETD-FMK and FITC-DEVD-FMK staining followed by flow cytometry.</s><s>Bars represent mean activation (±SD, error bars) in treatment groups from 3 independent experiments relative to untreated control cultures.</s><s>A synergist effect of the combined viscumTT extracts was calculated by Webb´s fractional product (*Fp &gt; 1).</s><s>B. TC-71 cells were treated with viscum, TT and viscumTT for 24h with or without 40μM Z-VAD-FMK (pan-caspase inhibitor), then apoptotic cells were detected using annexin V/propidium iodide staining and flow cytometry.</s><s>Bars represent the mean (±SD, error bars) of 3 independent experiments.</s><s>Results are expressed as percentages of the untreated control cultures.</s><s>Mistletoe lectin (ML) and oleanolic acid (OA) concentrations were used as a measure of viscum and TT active agent extract concentration, respectively.</s><s>doi:10.1371/journal.pone.0159749.g003</s></p></div></figDesc><graphic coords="9,123.82,78.01,452.13,331.88" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_7"><head>Fig 4 .</head><label>4</label><figDesc><div><p><s>Fig 4. Viscum, TT and viscumTT alter apoptosis-related protein expression.</s><s>A. Whole-cell protein extracts from TC-71 cells after 24h of treatment with viscum, TT or viscumTT concentrations approximating the IC50 were analyzed using the R&amp;D systems human proteome profiler apoptosis array (n = 1).</s><s>Bars represent the n-fold change in apoptosis-related protein expression relative to untreated control expression.</s><s>B. TC-71 and MHH-ES-1 cells were treated with viscum, TT or viscumTT at the concentrations shown for 24h, then expression of the apoptosis-related proteins indicated was examined in whole-cell lysates using western blotting.</s><s>Representative pictures are shown from 3 independent experiments.</s><s>Mistletoe lectin (ML) and oleanolic acid (OA) concentrations were used as a measure of viscum and TT active agent extract concentration, respectively.</s><s>doi:10.1371/journal.pone.0159749.g004</s></p></div></figDesc><graphic coords="10,47.96,78.01,528.23,369.75" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_8"><head>Fig 5 .</head><label>5</label><figDesc><div><p><s>Fig 5. ViscumTT and viscum induce apoptosis and inhibit proliferation ex vivo.</s><s>Primary Ewing sarcoma cells from a 15-year-old girl were grown as short-term cultures ex vivo, and treated with increasing concentrations of viscum, TT or viscumTT for 24h.</s><s>Induction of apoptosis (n = 4), proliferation inhibition (n = 2), mitochondrial membrane potential (n = 2) and activation of CASP8 and CASP9 (n = 2) were measured flow cytometrically with the same assays described for the cell lines.</s><s>Values are the means of n experiments ±SD (error bars).</s><s>Controls were untreated cultures grown in parallel.</s><s>A synergistic effect of the combined viscumTT extracts was calculated by Webb´s fractional product (*Fp &gt; 1).</s><s>Mistletoe lectin (ML) and oleanolic acid (OA) concentrations were used as a measure of viscum and TT active agent extract concentration, respectively.</s><s>doi:10.1371/journal.pone.0159749.g005</s></p></div></figDesc><graphic coords="11,47.96,78.01,528.23,293.44" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_9"><head>Fig 6 .</head><label>6</label><figDesc><div><p><s>Fig 6.</s><s>ViscumTT reduces the growth of human Ewing sarcoma xenograft tumors in mice.</s><s>Established Ewing sarcoma xenograft tumors were intratumorally (i.t.) injected with 40/50/60mg oleanolic acid/kg mouse weight (TT i.t.), 0.75/1.25/1.75μg</s><s>mistletoe lectin /kg mouse weight (viscum i.t.) or a combination thereof (viscumTT i.t.) every 2 to 3 days in increasing concentrations.</s><s>Each concentration was administered twice within 2-3 days.</s><s>One treatment group received viscumTT intravenously (i.v.), and one positive control group was once intravenously (i.v.) treated with 4 mg/kg doxorubicin.</s><s>The negative control group received the solubilizing agent, cyclodextrins (CD), which was injected either intratumorally (CD i.t.) or intravenously (CD i.v.).</s><s>One-way ANOVA revealed a significant group effect (p = 0.007) and Fisher´s Least Significant Difference test comparing all groups with all groups showed a significant effect between the CD i.t.</s><s>control group and viscumTT i.t.</s><s>(p = 0.033), viscum i.t.</s><s>(p = 0.002) and TT i.t.</s><s>(p = 0.021) as well as between the CD i.v.</s><s>control group and viscumTT i.v.</s><s>(p = 0.014) or the positive control group, doxorubicin i.v.</s><s>(p = 0.015).</s><s>Box-and-wisker plots each represent one treatment group including 8 mice (*p &lt; 0.05, **p &lt; 0.005).</s></p></div></figDesc><graphic coords="12,48.70,78.01,527.49,149.90" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_10"><head></head><label></label><figDesc><div><p><s>Fig 6.</s><s>ViscumTT reduces the growth of human Ewing sarcoma xenograft tumors in mice.</s><s>Established Ewing sarcoma xenograft tumors were intratumorally (i.t.) injected with 40/50/60mg oleanolic acid/kg mouse weight (TT i.t.), 0.75/1.25/1.75μg</s><s>mistletoe lectin /kg mouse weight (viscum i.t.) or a combination thereof (viscumTT i.t.) every 2 to 3 days in increasing concentrations.</s><s>Each concentration was administered twice within 2-3 days.</s><s>One treatment group received viscumTT intravenously (i.v.), and one positive control group was once intravenously (i.v.) treated with 4 mg/kg doxorubicin.</s><s>The negative control group received the solubilizing agent, cyclodextrins (CD), which was injected either intratumorally (CD i.t.) or intravenously (CD i.v.).</s><s>One-way ANOVA revealed a significant group effect (p = 0.007) and Fisher´s Least Significant Difference test comparing all groups with all groups showed a significant effect between the CD i.t.</s><s>control group and viscumTT i.t.</s><s>(p = 0.033), viscum i.t.</s><s>(p = 0.002) and TT i.t.</s><s>(p = 0.021) as well as between the CD i.v.</s><s>control group and viscumTT i.v.</s><s>(p = 0.014) or the positive control group, doxorubicin i.v.</s><s>(p = 0.015).</s><s>Box-and-wisker plots each represent one treatment group including 8 mice (*p &lt; 0.05, **p &lt; 0.005).</s><s>doi:10.1371/journal.pone.0159749.g006</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_11"><head>Fig 7 .</head><label>7</label><figDesc><div><p><s>Fig 7.  ViscumTT reduces the growth of patient-derived Ewing sarcoma xenograft tumors in mice.</s><s>Established Ewing sarcoma xenograft tumors in NMRI-nu/nu mice were intratumorally (i.t.) and intravenously (i.v.) injected with 40/60/80mg/kg oleanolic acid and 1.25/1.75/2.25μg/kg</s><s>mistletoe lectin in combination (viscumTT, low dose).</s><s>Additionally, mice were treated intratumorally (i.t.) with 50/70/90mg/kg oleanolic acid and 1.25/1.75/</s><s>2.25μg/kg mistletoe lectin in combination (viscumTT, high dose).</s><s>Viscum TT was given every 2-3 days in increasing extract concentrations.</s><s>One positive control group was treated twice intravenously (i.v.) with 4 mg/kg doxorubicin.</s><s>The negative control group received cyclodextrins (CD) intratumorally (CD i.t.).</s><s>One-way ANOVA revealed a strongly significant group effect (p &lt; 0.0001) and Fisher´s Least Significant Difference test comparing all groups with all groups showed a significant effect between the CD i.t.</s><s>control group and viscumTT i.t.</s><s>low dose (p = 0.006) and viscumTT i.t.</s><s>high dose (p = 0.003) Box-and-wisker plots each represent one treatment group including 5 mice (**p &lt; 0.005).</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_12"><head></head><label></label><figDesc><div><p><s>Fig 7.  ViscumTT reduces the growth of patient-derived Ewing sarcoma xenograft tumors in mice.</s><s>Established Ewing sarcoma xenograft tumors in NMRI-nu/nu mice were intratumorally (i.t.) and intravenously (i.v.) injected with 40/60/80mg/kg oleanolic acid and 1.25/1.75/2.25μg/kg</s><s>mistletoe lectin in combination (viscumTT, low dose).</s><s>Additionally, mice were treated intratumorally (i.t.) with 50/70/90mg/kg oleanolic acid and 1.25/1.75/</s><s>2.25μg/kg mistletoe lectin in combination (viscumTT, high dose).</s><s>Viscum TT was given every 2-3 days in increasing extract concentrations.</s><s>One positive control group was treated twice intravenously (i.v.) with 4 mg/kg doxorubicin.</s><s>The negative control group received cyclodextrins (CD) intratumorally (CD i.t.).</s><s>One-way ANOVA revealed a strongly significant group effect (p &lt; 0.0001) and Fisher´s Least Significant Difference test comparing all groups with all groups showed a significant effect between the CD i.t.</s><s>control group and viscumTT i.t.</s><s>low dose (p = 0.006) and viscumTT i.t.</s><s>high dose (p = 0.003) Box-and-wisker plots each represent one treatment group including 5 mice (**p &lt; 0.005).</s><s>doi:10.1371/journal.pone.0159749.g007</s></p></div></figDesc><graphic coords="13,57.88,78.01,518.11,384.72" type="bitmap" /></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">PLOS ONE | DOI:10.1371/journal.pone.0159749 September 2, 2016</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgments</head><p><s>This work was supported by the Software AG-Stiftung (Darmstadt, Germany) and the Federal Ministry for Economic Affairs and Energy on the basis of a decision by the German Bundestag.</s><s>EPO GmbH and Birken AG provided support in the form of salaries for authors JR and SJ respectively, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.</s><s>The authors thank K. Astrahantseff for comments on and editing of the manuscript.</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Author Contributions</head><p><s>Conceived and designed the experiments: GS CD MT.</s></p><p><s>Performed the experiments: MT SK JR.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Analyzed the data: MT CD GS.</head><p><s>Contributed reagents/materials/analysis tools: SJ JR AE.</s></p><p><s>Wrote the paper: MT AE.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">American Cancer Society: Cancer Facts and Figures</title>
	</analytic>
	<monogr>
		<title level="j">Society AC</title>
		<imprint>
			<date type="published" when="2014">2014. 2014</date>
		</imprint>
	</monogr>
	<note>American Cancer Society. available online</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">German Childhood Cancer Registry-Report</title>
		<author>
			<persName><forename type="first">P</forename><surname>Kaatsch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Spix</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Institute of Medical Biostatistics</title>
				<imprint>
			<date type="published" when="1980">2014. 2013/14 (1980-2013</date>
		</imprint>
		<respStmt>
			<orgName>IMBEI) at the University Medical Center of the Johannes Gutenberg University Mainz</orgName>
		</respStmt>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Modeling Initiation of Ewing Sarcoma in Human Neural Crest Cells</title>
		<author>
			<persName><forename type="first">C</forename><surname>Von Levetzow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Gwye</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Von Levetzow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Hung</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0019305</idno>
		<idno type="PMID">21559395</idno>
	</analytic>
	<monogr>
		<title level="j">PLoS ONE</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page">e19305</biblScope>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<monogr>
		<title level="m" type="main">Mesenchymal Stem Cells and the Origin of Ewing&apos;s Sarcoma. Sarcoma</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">P</forename><surname>Lin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Lozano</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2011">2011. 2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Ewing Sarcoma Protein: A Key Player in Human Cancer</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Paronetto</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">International Journal of Cell Biology</title>
		<imprint>
			<biblScope unit="page">12</biblScope>
			<date type="published" when="2013">2013. 2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Mining Sarcomas by Proteomics Approaches: Ewing Sarcoma on the Spotlight</title>
		<author>
			<persName><forename type="first">C</forename><surname>Mackintosh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Madoz-Gurpide</surname></persName>
		</author>
		<idno type="PMID">23848272</idno>
	</analytic>
	<monogr>
		<title level="j">Recent Pat Biotechnol</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="98" to="111" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Innovative Therapies in Ewing Sarcoma</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">T</forename><surname>Amaral</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Ordóñez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">P</forename><surname>Otero-Motta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>García-Domínguez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">V</forename><surname>Sevillano</surname></persName>
		</author>
		<idno type="DOI">10.1097/PAP.0000000000000003</idno>
		<idno type="PMID">24316910</idno>
	</analytic>
	<monogr>
		<title level="j">Advances in Anatomic Pathology</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="44" to="62" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Risk of recurrence and survival after relapse in patients with Ewing sarcoma</title>
		<author>
			<persName><forename type="first">M</forename><surname>Stahl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ranft</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Paulussen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Bölling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Vieth</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pediatric Blood &amp; Cancer</title>
		<imprint>
			<biblScope unit="volume">57</biblScope>
			<biblScope unit="page" from="549" to="553" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">BIRC5 expression is a poor prognostic marker in Ewing sarcoma</title>
		<author>
			<persName><forename type="first">P</forename><surname>Hingorani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Dickman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Garcia-Filion</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>White-Collins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Kolb</surname></persName>
		</author>
		<idno type="DOI">10.1002/pbc.24290</idno>
		<idno type="PMID">22961763</idno>
	</analytic>
	<monogr>
		<title level="j">Pediatr Blood Cancer</title>
		<imprint>
			<biblScope unit="volume">60</biblScope>
			<biblScope unit="page" from="35" to="40" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Survivin, a target to modulate the radiosensitivity of Ewing&apos;s sarcoma</title>
		<author>
			<persName><forename type="first">B</forename><surname>Greve</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Sheikh-Mounessi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Kemper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Ernst</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Gotte</surname></persName>
		</author>
		<idno type="DOI">10.1007/s00066-012-0223-z</idno>
		<idno type="PMID">23053158</idno>
	</analytic>
	<monogr>
		<title level="j">Strahlenther Onkol</title>
		<imprint>
			<biblScope unit="volume">188</biblScope>
			<biblScope unit="page" from="1038" to="1047" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Treat cancers by targeting survivin: Just a dream or future reality?</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Coumar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F-Y</forename><surname>Tsai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Kanwar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Sarvagalla</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Cha</forename><surname>Cheung</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ctrv.2013.02.002</idno>
		<idno type="PMID">23453862</idno>
	</analytic>
	<monogr>
		<title level="j">Cancer Treatment Reviews</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="page" from="802" to="811" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">X-linked Inhibitor of Apoptosis: A Chemoresistance Factor or a Hollow Promise</title>
		<author>
			<persName><forename type="first">H</forename><surname>Kashkar</surname></persName>
		</author>
		<idno type="DOI">10.1158/1078-0432.CCR-10-1664</idno>
		<idno type="PMID">20682709</idno>
	</analytic>
	<monogr>
		<title level="j">Clinical Cancer Research</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="4496" to="4502" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">X-Linked Inhibitor of Apoptosis Protein-A Critical Death Resistance Regulator and Therapeutic Target for Personalized Cancer Therapy</title>
		<author>
			<persName><forename type="first">P</forename><surname>Obexer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Ausserlechner</surname></persName>
		</author>
		<idno type="DOI">10.3389/fonc.2014.00197</idno>
		<idno type="PMID">25120954</idno>
	</analytic>
	<monogr>
		<title level="j">Frontiers in Oncology</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page">197</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Preclinical and Clinical Effects of Mistletoe against Breast Cancer</title>
		<author>
			<persName><forename type="first">M</forename><surname>Marvibaigi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Supriyanto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Amini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Abdul</forename><surname>Majid</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">A</forename><surname>Jaganathan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename></persName>
		</author>
		<idno type="DOI">10.1155/2014/785479</idno>
		<idno type="PMID">25136622</idno>
	</analytic>
	<monogr>
		<title level="j">Biomed Res Int</title>
		<imprint>
			<biblScope unit="page">785479</biblScope>
			<date type="published" when="2014">2014. 2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Isolation and properties of three lectins from mistletoe (Viscum album L.)</title>
		<author>
			<persName><forename type="first">H</forename><surname>Franz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Ziska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kindt</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BiochemJ</title>
		<imprint>
			<biblScope unit="volume">195</biblScope>
			<biblScope unit="page" from="481" to="484" />
			<date type="published" when="1981">1981</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Anti-inflammatory and antinociceptive activity of flavonoids isolated from Viscum album ssp. album</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">D</forename><surname>Orhan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Kupeli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Yesilada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Ergun</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">ZNaturforschC</title>
		<imprint>
			<biblScope unit="volume">61</biblScope>
			<biblScope unit="page" from="26" to="30" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Novel GHB-derived natural products from European mistletoe (Viscum album)</title>
		<author>
			<persName><forename type="first">B</forename><surname>Amer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">J</forename><surname>Juvik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">W</forename><surname>Francis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Fossen</surname></persName>
		</author>
		<idno type="DOI">10.3109/13880209.2013.773520</idno>
		<idno type="PMID">23734579</idno>
	</analytic>
	<monogr>
		<title level="j">Pharm Biol</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="page" from="981" to="986" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Diarylheptanoids and flavonoids from viscum album inhibit LPS-stimulated production of pro-inflammatory cytokines in bone marrow-derived dendritic cells</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">X</forename><surname>Nhiem</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">V</forename><surname>Kiem</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">V</forename><surname>Minh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Park</surname></persName>
		</author>
		<idno type="DOI">10.1021/np300490v</idno>
		<idno type="PMID">23484668</idno>
	</analytic>
	<monogr>
		<title level="j">J Nat Prod</title>
		<imprint>
			<biblScope unit="volume">76</biblScope>
			<biblScope unit="page" from="495" to="502" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Characterization of cytotoxic proteins from mistletoe (Viscum album L.)</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Jung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Baudino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Ribereau-Gayon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Beck</surname></persName>
		</author>
		<idno type="PMID">2344587</idno>
	</analytic>
	<monogr>
		<title level="j">Cancer Lett</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="page" from="103" to="108" />
			<date type="published" when="1990">1990</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Mistletoe lectin has a shiga toxin-like structure and should be combined with other Toll-like receptor ligands in cancer therapy</title>
		<author>
			<persName><forename type="first">C</forename><surname>Maletzki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Linnebacher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Savai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Hobohm</surname></persName>
		</author>
		<idno type="DOI">10.1007/s00262-013-1455-1</idno>
		<idno type="PMID">23832140</idno>
	</analytic>
	<monogr>
		<title level="j">Cancer Immunol Immunother</title>
		<imprint>
			<biblScope unit="volume">62</biblScope>
			<biblScope unit="page" from="1283" to="1292" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Cytotoxic effects of mistletoe (Viscum album L.) in head and neck squamous cell carcinoma cell lines</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">F</forename><surname>Klingbeil</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">C</forename><surname>Xavier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">R</forename><surname>Sardinha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Severino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">B</forename><surname>Mathor</surname></persName>
		</author>
		<idno type="DOI">10.3892/or.2013.2732</idno>
		<idno type="PMID">24026291</idno>
	</analytic>
	<monogr>
		<title level="j">Oncol Rep</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="2316" to="2322" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Extract from mistletoe, Viscum album L., reduces Hsp27 and 14-3-3 protein expression and induces apoptosis in C6 rat glioma cells</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">O</forename><surname>Ucar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Arda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Aitken</surname></persName>
		</author>
		<idno type="PMID">23007975</idno>
	</analytic>
	<monogr>
		<title level="j">Genet Mol Res</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="2801" to="2813" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Disappearance of an advanced adenomatous colon polyp after intratumoural injection with Viscum album (European mistletoe) extract: a case report</title>
		<author>
			<persName><forename type="first">T</forename><surname>Von Schoen-Angerer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Goyert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Vagedes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kiene</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Merckens</surname></persName>
		</author>
		<idno type="DOI">10.15403/jgld.2014.1121.234.acpy</idno>
		<idno type="PMID">25532007</idno>
	</analytic>
	<monogr>
		<title level="j">J Gastrointestin Liver Dis</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="449" to="452" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Solubility studies of oleanolic acid and betulinic acid in aqueous solutions and plant extracts of Viscum album L</title>
		<author>
			<persName><forename type="first">S</forename><surname>Jäger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Winkler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Pfüller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Scheffler</surname></persName>
		</author>
		<idno type="PMID">17415876</idno>
	</analytic>
	<monogr>
		<title level="j">Planta Med</title>
		<imprint>
			<biblScope unit="volume">73</biblScope>
			<biblScope unit="page" from="157" to="162" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">3-O-[N-(p-fluorobenzenesulfonyl)-carbamoyl]-oleanolic acid, a semisynthetic analog of oleanolic acid, induces apoptosis in breast cancer cells</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Akl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">E</forename><surname>Elsayed</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">Y</forename><surname>Ebrahim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">G</forename><surname>Haggag</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Kamal</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ejphar.2014.07.011</idno>
		<idno type="PMID">25046839</idno>
	</analytic>
	<monogr>
		<title level="j">Eur J Pharmacol</title>
		<imprint>
			<biblScope unit="volume">740</biblScope>
			<biblScope unit="page" from="209" to="217" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">High sensitivity of ovarian cancer cells to the synthetic triterpenoid CDDO-Imidazolide</title>
		<author>
			<persName><forename type="first">A</forename><surname>Petronelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Saulle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Pasquini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Petrucci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Mariani</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.canlet.2009.03.018</idno>
		<idno type="PMID">19364626</idno>
	</analytic>
	<monogr>
		<title level="j">Cancer Lett</title>
		<imprint>
			<biblScope unit="volume">282</biblScope>
			<biblScope unit="page" from="214" to="228" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Oleanolic acid initiates apoptosis in non-small cell lung cancer cell lines and reduces metastasis of a B16F10 melanoma model in vivo</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Lucio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Rocha Gda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">C</forename><surname>Moncao-Ribeiro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Fernandes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Takiya</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0028596</idno>
		<idno type="PMID">22174843</idno>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page">e28596</biblScope>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Betulinic acid: a new chemotherapeutic agent in the treatment of neuroectodermal tumors</title>
		<author>
			<persName><forename type="first">S</forename><surname>Fulda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jeremias</forename><forename type="middle">I</forename><surname>Pietsch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Debatin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename></persName>
		</author>
		<idno type="PMID">10472570</idno>
	</analytic>
	<monogr>
		<title level="j">Klin Padiatr</title>
		<imprint>
			<biblScope unit="volume">211</biblScope>
			<biblScope unit="page" from="319" to="322" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">The synergistic biologic activity of oleanolic and ursolic acids in complex with hydroxypropyl-gamma-cyclodextrin</title>
		<author>
			<persName><forename type="first">C</forename><surname>Soica</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Oprean</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Borcan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Danciu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Trandafirescu</surname></persName>
		</author>
		<idno type="DOI">10.3390/molecules19044924</idno>
		<idno type="PMID">24747649</idno>
	</analytic>
	<monogr>
		<title level="j">Molecules</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="4924" to="4940" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">A new development of triterpene acid-containing extracts from Viscum album L. displays synergistic induction of apoptosis in acute lymphoblastic leukaemia</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">I</forename><surname>Delebinski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Jäger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Kemnitz-Hassanin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Henze</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">N</forename><surname>Lode</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1365-2184.2011.00801.x</idno>
		<idno type="PMID">22221251</idno>
	</analytic>
	<monogr>
		<title level="j">Cell Proliferation</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="page" from="176" to="187" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">A Natural Combination Extract of Viscum album L. Containing Both Triterpene Acids and Lectins Is Highly Effective against AML In Vivo</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">I</forename><surname>Delebinski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Twardziok</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kleinsimon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Hoff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Mulsow</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0133892</idno>
		<idno type="PMID">26244918</idno>
	</analytic>
	<monogr>
		<title level="j">PLoS ONE</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page">e0133892</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Triterpenoids amplify antitumoral effects of mistletoe extracts on murine B16.f10 melanoma in vivo</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Strüh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Jäger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kersten</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Schempp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Scheffler</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0062168</idno>
		<idno type="PMID">23614029</idno>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page">e62168</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">A Novel Triterpene Extract from Mistletoe Induces Rapid Apoptosis in Murine B16.F10 Melanoma Cells</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Strüh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Jäger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Schempp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Scheffler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">F</forename><surname>Martin</surname></persName>
		</author>
		<idno type="DOI">10.1002/ptr.4604</idno>
		<idno type="PMID">22318938</idno>
	</analytic>
	<monogr>
		<title level="j">Phytotherapy Research</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="1507" to="1512" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Quantitative determination of lectins in mistletoe preparations</title>
		<author>
			<persName><forename type="first">C</forename><surname>Jaggy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Musielski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Urech</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Schaller</surname></persName>
		</author>
		<idno type="PMID">7575759</idno>
	</analytic>
	<monogr>
		<title level="j">Arzneimittelforschung</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="page" from="905" to="909" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">The pathophysiology of mitochondrial cell death</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Green</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Kroemer</surname></persName>
		</author>
		<idno type="PMID">15286356</idno>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">305</biblScope>
			<biblScope unit="page" from="626" to="629" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Mitochondria in chemotherapy-induced apoptosis: a prospective novel target of cancer therapy (review)</title>
		<author>
			<persName><forename type="first">D</forename><surname>Decaudin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Marzo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Brenner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Kroemer</surname></persName>
		</author>
		<idno type="PMID">9454898</idno>
	</analytic>
	<monogr>
		<title level="j">Int J Oncol</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="141" to="152" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">NOXA as critical mediator for drug combinations in polychemotherapy</title>
		<author>
			<persName><forename type="first">H</forename><surname>Ehrhardt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Hofig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Wachter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Obexer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Fulda</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell DeathDis</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page">e327</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Study of Costus lucanusianus: plant juice, fraction combinations and pharmacologie estimation of natural product total activity</title>
		<author>
			<persName><forename type="first">S</forename><surname>Foungbé</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Kouassi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Kablan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Marcy</surname></persName>
		</author>
		<idno type="PMID">1921417</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Ethnopharmacology</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="page" from="221" to="226" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Natural products and drug discovery. Can thousands of years of ancient medical knowledge lead us to new and powerful drug combinations in the fight against cancer and dementia?</title>
		<author>
			<persName><forename type="first">H-F</forename><surname>Ji</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X-J</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H-Y</forename><surname>Zhang</surname></persName>
		</author>
		<idno type="DOI">10.1038/embor.2009.12</idno>
		<idno type="PMID">19229284</idno>
	</analytic>
	<monogr>
		<title level="j">EMBO Reports</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="194" to="200" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Mistletoe lectin activates caspase-8/FLICE independently of death receptor signaling and enhances anticancer drug-induced apoptosis</title>
		<author>
			<persName><forename type="first">H</forename><surname>Bantel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">H</forename><surname>Engels</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Voelter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Schulze-Osthoff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Wesselborg</surname></persName>
		</author>
		<idno type="PMID">10232592</idno>
	</analytic>
	<monogr>
		<title level="j">Cancer Res</title>
		<imprint>
			<biblScope unit="volume">59</biblScope>
			<biblScope unit="page" from="2083" to="2090" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Activation of caspase cascades in Korean mistletoe (Viscum album var. coloratum) lectin-II-induced apoptosis of human myeloleukemic U937 cells</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">S</forename><surname>So</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Lee</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">GenPharmacol</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="349" to="355" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Recombinant VAA-I from Viscum album induces apoptotic cell death of hepatocellular carcinoma SMMC7721 cells</title>
		<author>
			<persName><forename type="first">X</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Xie</surname></persName>
		</author>
		<idno type="DOI">10.3390/molecules171011435</idno>
		<idno type="PMID">23014500</idno>
	</analytic>
	<monogr>
		<title level="j">Molecules</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="11435" to="11446" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Cell-type dependence of stability modulation of lectin-initiated contacts by impairment of multivalent carbohydrate binding and intracellular signaling</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">V</forename><surname>Timoshenko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">V</forename><surname>Gorudko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Andre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Gabius</surname></persName>
		</author>
		<idno type="PMID">11095119</idno>
	</analytic>
	<monogr>
		<title level="j">Biosci Rep</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="199" to="209" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">The novel triterpenoid CDDO induces apoptosis and differentiation of human osteosarcoma cells by a caspase-8 dependent mechanism</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Ito</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Pandey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">B</forename><surname>Sporn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Datta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kharbanda</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">MolPharmacol</title>
		<imprint>
			<biblScope unit="volume">59</biblScope>
			<biblScope unit="page" from="1094" to="1099" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">In vitro anti-breast cancer activity of ethanolic extract of Wrightia tomentosa: role of pro-apoptotic effects of oleanolic acid and urosolic acid</title>
		<author>
			<persName><forename type="first">B</forename><surname>Chakravarti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Maurya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Siddiqui</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">K</forename><surname>Bid</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Rajendran</surname></persName>
		</author>
		<idno type="PMID">22855944</idno>
	</analytic>
	<monogr>
		<title level="j">J Ethnopharmacol</title>
		<imprint>
			<biblScope unit="volume">142</biblScope>
			<biblScope unit="page" from="72" to="79" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Oleanolic acid and ursolic acid induce apoptosis in four human liver cancer cell lines</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Yan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">Y</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">T</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Yin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">ToxicolIn Vitro</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="842" to="848" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">Oleanolic Acid and Ursolic Acid Induce Apoptosis in HuH7 Human Hepatocellular Carcinoma Cells through a Mitochondrial-Dependent Pathway and Downregulation of XIAP</title>
		<author>
			<persName><forename type="first">M-H</forename><surname>Shyu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T-C</forename><surname>Kao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Yen</forename></persName>
		</author>
		<author>
			<persName><forename type="first">G-C</forename></persName>
		</author>
		<idno type="DOI">10.1021/jf100574j</idno>
		<idno type="PMID">20415421</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Agricultural and Food Chemistry</title>
		<imprint>
			<biblScope unit="volume">58</biblScope>
			<biblScope unit="page" from="6110" to="6118" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Oleanolic acid arrests cell cycle and induces apoptosis via ROS-mediated mitochondrial depolarization and lysosomal membrane permeabilization in human pancreatic cancer cells</title>
		<author>
			<persName><forename type="first">J</forename><surname>Wei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Wang</surname></persName>
		</author>
		<idno type="DOI">10.1002/jat.2725</idno>
		<idno type="PMID">22678527</idno>
	</analytic>
	<monogr>
		<title level="j">J Appl Toxicol</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="page" from="756" to="765" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">The Synthetic Triterpenoid 2-Cyano-3,12-dioxooleana-1,9-dien-28-oic Acid Induces Caspase-Dependent and -Independent Apoptosis in Acute Myelogenous Leukemia</title>
		<author>
			<persName><forename type="first">M</forename><surname>Konopleva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Tsao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Estrov</surname></persName>
		</author>
		<author>
			<persName><surname>Lee R-M</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R-Y</forename><surname>Wang</surname></persName>
		</author>
		<idno type="PMID">15520199</idno>
	</analytic>
	<monogr>
		<title level="j">Cancer Research</title>
		<imprint>
			<biblScope unit="volume">64</biblScope>
			<biblScope unit="page" from="7927" to="7935" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">In vitro and in vivo antimammary tumor activities and mechanisms of the apple total triterpenoids</title>
		<author>
			<persName><forename type="first">X</forename><surname>He</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Hu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Zhang</surname></persName>
		</author>
		<idno type="PMID">22924395</idno>
	</analytic>
	<monogr>
		<title level="j">J Agric Food Chem</title>
		<imprint>
			<biblScope unit="volume">60</biblScope>
			<biblScope unit="page" from="9430" to="9436" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">Apoptosis of K562 leukemia cells by Abnobaviscum F(R), a European mistletoe extract</title>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">K</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">R</forename><surname>Do</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">C</forename><surname>Jang</surname></persName>
		</author>
		<idno type="DOI">10.3892/or.2012.2026</idno>
		<idno type="PMID">22972372</idno>
	</analytic>
	<monogr>
		<title level="j">Oncol Rep</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="2227" to="2232" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">Oleanane triterpenoid CDDO-Me induces apoptosis in multidrug resistant osteosarcoma cells through inhibition of Stat3 pathway</title>
		<author>
			<persName><forename type="first">K</forename><surname>Ryu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Susa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Choy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">J</forename><surname>Hornicek</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMCCancer</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page">187</biblScope>
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">Synthesis of novel heterocyclic oleanolic acid derivatives with improved antiproliferative activity in solid tumor cells</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Leal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Salvador</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Jing</surname></persName>
		</author>
		<idno type="DOI">10.1039/c3ob00011g</idno>
		<idno type="PMID">23381885</idno>
	</analytic>
	<monogr>
		<title level="j">Org Biomol Chem</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="1726" to="1738" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">Characterization and Drug Resistance Patterns of Ewing&apos;s Sarcoma Family Tumor Cell Lines</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">A</forename><surname>May</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Grigoryan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Keshelava</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Cabral</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">L</forename><surname>Christensen</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0080060</idno>
		<idno type="PMID">24312454</idno>
	</analytic>
	<monogr>
		<title level="j">PLoS ONE</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page">e80060</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main">Induction of apoptosis by the N-acetylgalactosamine-specific toxic lectin from Viscum album L. is associated with a decrease of nuclear p53 and Bcl-2 proteins and induction of telomeric associations</title>
		<author>
			<persName><forename type="first">A</forename><surname>Büssing</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Multani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Pathak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Pfüller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Schietzel</surname></persName>
		</author>
		<idno type="PMID">9751257</idno>
	</analytic>
	<monogr>
		<title level="j">Cancer Lett</title>
		<imprint>
			<biblScope unit="volume">130</biblScope>
			<biblScope unit="page" from="57" to="68" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main">TopBP1 and Claspin contribute to the radioresistance of lung cancer brain metastases</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Choi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J-H</forename><surname>Ki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D-H</forename><surname>Nam</surname></persName>
		</author>
		<idno type="DOI">10.1186/1476-4598-13-211</idno>
		<idno type="PMID">25216549</idno>
	</analytic>
	<monogr>
		<title level="j">Molecular Cancer</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page">211</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main">To fight or die: inhibitor of apoptosis proteins at the crossroad of innate immunity and death</title>
		<author>
			<persName><forename type="first">J</forename><surname>Lopez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Meier</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ceb.2010.08.025</idno>
		<idno type="PMID">20888210</idno>
	</analytic>
	<monogr>
		<title level="j">Current Opinion in Cell Biology</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="872" to="881" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main">The inhibitor of apoptosis (IAP) proteins are critical regulators of signaling pathways and targets for anti-cancer therapy</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>De Almagro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Vucic</surname></persName>
		</author>
		<idno type="PMID">23070005</idno>
	</analytic>
	<monogr>
		<title level="j">Exp Oncol</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="200" to="211" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main">CDDO-Me, a synthetic triterpenoid, inhibits expression of IL-6 and Stat3 phosphorylation in multi-drug resistant ovarian cancer cells</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Duan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Ames</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ryan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">J</forename><surname>Hornicek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Mankin</surname></persName>
		</author>
		<idno type="DOI">10.1007/s00280-008-0785-8</idno>
		<idno type="PMID">18587580</idno>
	</analytic>
	<monogr>
		<title level="j">Cancer chemotherapy and pharmacology</title>
		<imprint>
			<biblScope unit="volume">63</biblScope>
			<biblScope unit="page" from="681" to="689" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title level="a" type="main">Betulinic Acid Derivatives NVX-207 and B10 for Treatment of Glioblastoma-An in Vitro Study of Cytotoxicity and Radiosensitization</title>
		<author>
			<persName><forename type="first">M</forename><surname>Bache</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Bernhardt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Passin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Wichmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Hein</surname></persName>
		</author>
		<idno type="DOI">10.3390/ijms151119777</idno>
		<idno type="PMID">25361208</idno>
	</analytic>
	<monogr>
		<title level="j">International Journal of Molecular Sciences</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="19777" to="19790" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b60">
	<analytic>
		<title level="a" type="main">Pharmacokinetics of natural mistletoe lectins after subcutaneous injection</title>
		<author>
			<persName><forename type="first">R</forename><surname>Huber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Eisenbraun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Miletzki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Adler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Scheer</surname></persName>
		</author>
		<idno type="DOI">10.1007/s00228-010-0830-5</idno>
		<idno type="PMID">20467733</idno>
	</analytic>
	<monogr>
		<title level="j">Eur J Clin Pharmacol</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="page" from="889" to="897" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b61">
	<analytic>
		<title level="a" type="main">Modulation of mistletoe (Viscum album L.) lectins cytotoxicity by carbohydrates and serum glycoproteins</title>
		<author>
			<persName><forename type="first">M</forename><surname>Frantz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Jung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Ribereau-Gayon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Anton</forename><forename type="middle">R</forename></persName>
		</author>
		<idno type="PMID">10858875</idno>
	</analytic>
	<monogr>
		<title level="j">Arzneimittelforschung</title>
		<imprint>
			<biblScope unit="volume">50</biblScope>
			<biblScope unit="page" from="471" to="478" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b62">
	<analytic>
		<title level="a" type="main">Interleukin-12 is associated with the in vivo anti-tumor effect of mistletoe extracts in B16 mouse melanoma</title>
		<author>
			<persName><forename type="first">Duong</forename><surname>Van Huyen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Delignat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Bayry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kazatchkine</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Bruneval</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename></persName>
		</author>
		<idno type="PMID">16412563</idno>
	</analytic>
	<monogr>
		<title level="j">Cancer Lett</title>
		<imprint>
			<biblScope unit="volume">243</biblScope>
			<biblScope unit="page" from="32" to="37" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b63">
	<analytic>
		<title level="a" type="main">Molecular mechanisms of mistletoe plant extract-induced apoptosis in acute lymphoblastic leukemia in vivo and in vitro</title>
		<author>
			<persName><forename type="first">G</forename><surname>Seifert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jesse</forename><forename type="middle">P</forename><surname>Laengler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Reindl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Luth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename></persName>
		</author>
		<idno type="DOI">10.1016/j.canlet.2008.01.036</idno>
		<idno type="PMID">18314258</idno>
	</analytic>
	<monogr>
		<title level="j">Cancer Lett</title>
		<imprint>
			<biblScope unit="volume">264</biblScope>
			<biblScope unit="page" from="218" to="228" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b64">
	<analytic>
		<title level="a" type="main">Standardized mistletoe extract augments immune response and down-regulates local and metastatic tumor growth in murine models</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Braun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">L</forename><surname>Ko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Schierholz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Beuth</surname></persName>
		</author>
		<idno type="PMID">12553054</idno>
	</analytic>
	<monogr>
		<title level="j">Anticancer Res</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="4187" to="4190" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b65">
	<analytic>
		<title level="a" type="main">Oleanolic acid derivative Dex-OA has potent anti-tumor and anti-metastatic activity on osteosarcoma cells in vitro and in vivo</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Hua</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Hu</surname></persName>
		</author>
		<idno type="DOI">10.1007/s10637-009-9354-1</idno>
		<idno type="PMID">19943081</idno>
	</analytic>
	<monogr>
		<title level="j">Investigational New Drugs</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="258" to="265" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b66">
	<analytic>
		<title level="a" type="main">Triterpenoids CDDO-methyl ester or CDDO-ethyl amide and rexinoids LG100268 or NRX194204 for prevention and treatment of lung cancer in mice</title>
		<author>
			<persName><forename type="first">K</forename><surname>Liby</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Risingsong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Royce</forename><forename type="middle">Db</forename><surname>Williams</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">R</forename><surname>Ma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer PrevRes(Phila)</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="1050" to="1058" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
